Dawn-Bio
Biotechnology Research
Wien, At
8 employees
- Employees
- 8
- Contacts
- 3
- Emails
- 3
Dawn-Bio Overview
- Headquarters
- Wien, At
- Website
- www.dawn-bio.com
- Industry
- Biotechnology Research
- Employees
- 8
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About Dawn-Bio
dawn-bio is a biotechnology company dedicated to advancing treatments for the millions of people silently struggling with infertility. With our groundbreaking platform technology - a human stem cell-based embryo and implantation model – we are uniquely equipped to discover and develop molecules that enhance healthy live births in IVF. Today, IVF clinics choose the best embryos. With dawn-bio, they will be able to change their trajectory for the better.
Dawn-Bio Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
Dawn-Bio Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Alok Javali | Cso and Co-founder at Dawn-bio - Redefining What’s Possible in Reproductive Medicine | Vienna, Austria |
Email
|
| Peter Greiner | CEO & Co-founder of Dawn-bio - Redefining What’s Possible in Reproductive Medicine |
View
|
|
| Nicolas Rivron | Principal Investigator at the Institute of Molecular Biotechnology, Austrian Academy of Science | Austria |
Email
|
| Elisabetta Ferretti | Project Manager at Dawn-bio - Redefining What’s Possible in Reproductive Medicine. | Copenhagen, Capital Region of Denmark, Denmark |
Email
|
Employees by Management Level
Executive
2 profiles
Manager
1 profile
Senior / Lead
1 profile
Compare Similar Companies to Dawn-Bio
Institute of Molecular Biotechnology
Research Services
BioInnovation Institute
Biotechnology Research
Vienna BioCenter
Research Services
Aida Oncology
Biotechnology Research
3B Future Health Fund I & II
Venture Capital And Private Equity Principals
Nordic Women's Health Hub
Non-Profit Organizations
Notify Therapeutics
Hospitals And Health Care
Femtech Studios
Venture Capital And Private Equity Principals
Dawn Biopharma
Biotechnology
Probmet Therapeutics
Biotechnology Research